×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
LON:CBX

Cellular Goods Share Forecast, Price & News

GBX 1.08
0.00 (0.00%)
(As of 07/4/2022 12:00 AM ET)
Add
Compare
Today's Range
1.05
1.14
50-Day Range
N/A
52-Week Range
1
11.70
Volume
697,026 shs
Average Volume
2.35 million shs
Market Capitalization
£5.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Cellular Goods MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.46 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive CBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellular Goods and its competitors with MarketBeat's FREE daily newsletter.

About Cellular Goods

Cellular Goods PLC, together with its subsidiaries, manufactures and sells biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online. The company was formerly known as Leaf Studios PLC and changed its name to Cellular Goods PLC in September 2020. Cellular Goods PLC was incorporated in 2018 and is based in London, United Kingdom.

CBX Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry
Pharmaceutical Retailers
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£13,058.00
Cash Flow
GBX 1.30 per share
Book Value
GBX 1.60 per share

Miscellaneous

Free Float
N/A
Market Cap
£5.45 million
Optionable
Optionable
Beta
N/A














Cellular Goods Frequently Asked Questions

How has Cellular Goods' stock price performed in 2022?

Cellular Goods' stock was trading at GBX 1.73 on January 1st, 2022. Since then, CBX stock has decreased by 37.8% and is now trading at GBX 1.08.
View the best growth stocks for 2022 here
.

Who are Cellular Goods' key executives?

Cellular Goods' management team includes the following people:
  • Mr. Simon Howard Walters ACA, Fin. Director, Company Sec. & Director (Age 58, Pay $106.64k)
  • Mr. Alexis Abraham, Chief Strategy Officer & Director (Age 40, Pay $132k)
  • Ms. Anna Chokina, Chief Exec. Officer
  • Neil Thapar, Investor Relations
  • Sean O'Dwyer, Marketing Director
  • Ms. Alexia Blake, Head of Research & Product Devel.
  • Mr. Istok Nahtigal, Head of Process & Applied Sciences
  • Mr. Nikhil Vijayan, Chief Supply Chain Officer
  • Jodie Sanders, Commercial & Partnerships Director
  • Mr. Anthony Buck, Skincare Adviser

What is Cellular Goods' stock symbol?

Cellular Goods trades on the London Stock Exchange (LON) under the ticker symbol "CBX."

How do I buy shares of Cellular Goods?

Shares of CBX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Cellular Goods' stock price today?

One share of CBX stock can currently be purchased for approximately GBX 1.08.

How much money does Cellular Goods make?

Cellular Goods (LON:CBX) has a market capitalization of £5.45 million and generates £13,058.00 in revenue each year.

This page (LON:CBX) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.